Physician profile
Shahram Askari
NPI 1184885659
$898.75
in general payments reported to CMS, 2019-2025
18 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $124 · 2022: $162 · 2023: $168 · 2024: $52.55 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $247.71 | 2021-2025 | Citrefix, Augment Injectable, Easyfuse |
| Medtronic Vascular, INC. | $129.10 | 2019 | |
| Djo, LLC | $76.93 | 2022-2023 | Cmf |
| Paratek Pharmaceuticals, INC. | $59.96 | 2024-2025 | Nuzyra, Xhance |
| Orthofix Medical, INC. | $59.03 | 2019-2023 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.86 | 2021-2023 | Jublia |
| Tactile Systems Technology INC | $41.94 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Wright Medical Technology, INC. | $36.95 | 2019 | |
| Aap Implants INC | $31.00 | 2021-2022 | |
| Organogenesis INC. | $28.16 | 2022 | |
| Arteriocyte Medical Systems, INC. | $23.15 | 2022 | |
| Abbott Laboratories | $19.90 | 2023 | Proclaim |
| Mimedx Group, INC. | $19.65 | 2025 | |
| Integra Lifesciences Corporation | $19.02 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $14.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $13.48 | 2019 | |
| Horizon Therapeutics Plc | $12.07 | 2019 | |
| Bioventus LLC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahram Askari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.